Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Searches
(0)
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Online First
Supplements
NCCN Meeting Highlights
JNCCN In the News
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
EPR21-034: Epidemiology of Diffuse Large B Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL) Patients by Line of Therapy in the United States (US) and Europe (EU)
Authors:
Wenzhen Ge
PhD
1
,
Jon E. Arnason
MD
2
,
Ruben G.W. Quek
PhD
1
,
Katie Keeven
MA
3
,
Knar Nersesyan
MA, MS
3
and
Gena Kanas
MPH, PhD
3
View More
View Less
1
Regeneron Pharmaceuticals Inc., Tarrytown, NY
2
Beth Israel Deaconess Medical Center, Boston, MA
3
Kantar - Health Division, New York, NY
Volume/Issue:
Volume 19: Issue 3.5
Online Publication Date:
17 Mar 2021
DOI:
https://doi.org/10.6004/jnccn.2020.7742
Restricted access
Purchase article (
USD
$0.01
)
Citation Alert
Get Permissions
Article Details
Corresponding Author: Gena Kanas, MPH, PhD
Print
Collapse
Expand
Top
Article Information
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Page Numbers:
EPR21-034
Article Category:
Abstract
Print Publication Date:
20 Mar 2021
Online Publication Date:
17 Mar 2021
Citation Alert
Get Permissions
PubMed
Article by Wenzhen Ge
Article by Jon E. Arnason
Article by Ruben G.W. Quek
Article by Katie Keeven
Article by Knar Nersesyan
Article by Gena Kanas
Google Scholar
Article by Wenzhen Ge
Article by Jon E. Arnason
Article by Ruben G.W. Quek
Article by Katie Keeven
Article by Knar Nersesyan
Article by Gena Kanas
Similar articles in Google Scholar
Related Articles
Metrics
All Time
Past Year
Past 30 Days
Abstract Views
0
0
0
Full Text Views
106
106
56
PDF Downloads
174
174
63
EPUB Downloads
0
0
0
[18.206.177.17]
18.206.177.17
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save